Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free MTNB Stock Alerts

Matinas Biopharma (MTNB) SEC Filings & 10K Form

Matinas Biopharma logo
$0.55 -0.02 (-3.81%)
(As of 12/20/2024 05:31 PM ET)
Compare

Recent Matinas Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
11/13/2024
4:16 PM		Matinas Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
5:31 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
8:15 AM		HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Matinas Biopharma (Subject)
Form SC 13G
09/03/2024
7:56 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
8:39 PM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:06 PM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
6:00 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
3:15 PM		Matinas Biopharma (Filer)
Form 424B5
03/28/2024
8:00 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:22 PM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:22 PM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
7:05 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
8:20 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
5:35 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
7:05 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
6:35 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
6:30 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
6:40 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
6:40 AM		Matinas Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:MTNB) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Video: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You
“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...
Brownstone Research | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored